Back

The IAM1000 is an influential directory of intellectual property professionals and Schlich has been recognised by the IAM1000 as “Recommended” for patent prosecution in the 2019–2020 edition. Also, George Schlich has again been recognised individually for his achievement and expertise.

“South coast patent attorney firm Schlich Ltd is living proof that you don’t need to be located in London to be take centre stage in some of the hottest European patent debates. The “meticulous, highly responsive and pleasant” side has been instrumental in the CRISPR EPO oppositions that will help determine the regulatory future of the revolutionary gene-editing technology. It also carries out work for leading pharmaceutical outfit AbbVie in relation to oncology and antibody-drug conjugate technologies. Its talisman is George Schlich, a Cambridge-educated natural scientist with a well-rounded command of most life sciences and mathematical areas. Peers and clients hold him in high regard. “He provides outstanding, high quality answers to complex questions in the CRISPR arena.” “George has built up an enviable reputation – he is a competitor that I greatly admire for his strong work ethic, quality and ability to build up a practice and company on his own.”

Share this article

Our news articles are for general information only. They should not be considered specific legal advice, which is available on request.


Our articles are for general information only. They should not be considered specific legal advice, which is available upon request. All information in our articles is considered to be accurate at the date of publishing.

Latest Firm News

Schlich Walks for Mental Health Awareness Week

Schlich Walks for Mental Health Awareness Week

With the sun making an appearance and this week being Mental Health Awareness Week we have swapped our treadmill team effort and decided to join the ‘2024 Mental Health – Moving More Challenge’ by taking ourselves away from our desks and walking along the seafront during our lunch breaks. 

read more